Bayfield Therapeutics

Moffitt Cancer Center, one of the nation’s leading cancer care and research institutions, and Deerfield Management, a health care investment firm, announced in September 2022 a major translational research alliance to accelerate the development of new therapeutics to treat cancer. Through a newly launched company called Bayfield Therapeutics LLC, Deerfield has committed up to $130 million over the next 10 years to this new collaboration. Its goal is to fund projects that have uncovered novel therapeutics that have the potential to cure life-altering diseases. This collaboration will build upon the robust drug pipeline already established by scientists at Moffitt.

Deerfield is an investment management firm committed to advancing healthcare through investment, information and philanthropy. The Firm works across the healthcare ecosystem to connect people, capital, ideas and technology in bold, collaborative and inclusive ways. For more information, please visit www.deerfield.com.

Moffitt is dedicated to one lifesaving mission: to contribute to the prevention and cure of cancer. The Tampa-based facility is one of only 54 National Cancer Institute-designated Comprehensive Cancer Centers, a distinction that recognizes Moffitt’s scientific excellence, multidisciplinary research, and robust training and education. Moffitt’s expert nursing staff is recognized by the American Nurses Credentialing Center with Magnet® status, its highest distinction. With more than 8,500 team members, Moffitt has an economic impact in the state of $2.4 billion. For more information, call 1-888-MOFFITT (1-888-663-3488), visit MOFFITT.org, and follow the momentum on Facebook, Twitter, Instagram and YouTube.

MOFFITT CANCER CENTER AND
DEERFIELD MANAGEMENT LAUNCH
BAYFIELD THERAPEUTICS

September 2022

Pre-Submission
Diligence

Moffitt Cancer Center
works with Faculty to Outline Their Idea

Proposal Concept Sheet Completion

Initial Project
Proposal
Evaluation

Letter of Intent

Application Submission & Further Project Evaluation

Full Proposal
Development

Work Plan Development and PI Presentation

Project
Acceptance and
Execution

Investment Evaluation Program funding via Bayfield
Therapeutics

How To Apply

For more information on proposal submissions, please reach out to Moffitt Cancer Center’s Office of Innovation at innovation@moffitt.org.

FREQUENTLY ASKED QUESTIONS (FAQ)

Submission Disclosure

Bayfield Therapeutics makes information about application process available to users who provide their personally identifiable information. If you do not wish to provide the information requested above, simply do not submit request to receive the application information. Please note that you are not required to provide your personal information or register to use this Site. By submitting your information, you are: (i) representing and warranting that you agree, and have the capacity to agree, to the Terms of Use and Privacy Policy (ii) providing your consent to receive electronic communications from Bayfield Therapeutics, and (iii) representing that the information you have provided is complete and accurate. Each submission of information is for a single individual only. You understand that Bayfield Therapeutics does not guarantee or warrant that the RFP application form it provides you be free of viruses or other destructive code. You are responsible for implementing sufficient procedures and checkpoints to satisfy your requirements The RFP application form is made available to you solely for your personal, non-commercial use, and you are prohibited from using, reproducing, modifying, transferring, exploiting, or distributing of any of the material provided to you for any other purpose. Bayfield Therapeutics makes no representation that the requested material is appropriate or available for use in locations outside of the United States. If you choose to request the material from outside of the United States, you do so on your own initiative and are responsible for compliance with the applicable local laws.